Commission Implementing Regulation (EU) 2017/2065 of 13 November 2017 confirming the conditions of approval of the active substance 8-hydroxyquinoline, as set out in Implementing Regulation (EU) No 540/2011 and modifying Implementing Regulation (EU) 2015/408 as regards the inclusion of the active substance 8-hydroxyquinoline in the list of candidates for substitution (Text with EEA relevance. )
Artículo 2Amendment to the Annex to Implementing Regulation (EU) 2015/408
Vigente · versión de 4 dic 2017
The name ‘8-hydroxyquinoline’ is inserted between the entry ‘1-methylcyclopropene’ and the entry ‘aclonifen’.